Brief: BioSyent Announces Notice Of Deficiency For Cardiovascular Products
22/03/2019 22:07
March 22 (Reuters) - Biosyent Inc RX.V :
* BIOSYENT ANNOUNCES NOTICE OF DEFICIENCY FOR CARDIOVASCULAR
PRODUCTS
* BIOSYENT - INFORMED BY HEALTH CANADA THAT CO WILL RECEIVE
NOTICE
OF DEFICIENCY RELATED TO NEW DRUG SUBMISSIONS OF TWO
CARDIOVASCULAR PRODUCTS
Source text for Eikon: ID:nGNX91vXlm
Further company coverage: RX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid